These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 33643322)
1. Mechanisms of Antibiotic Failure During Gimza BD; Cassat JE Front Immunol; 2021; 12():638085. PubMed ID: 33643322 [No Abstract] [Full Text] [Related]
2. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. Conlon BP Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240 [TBL] [Abstract][Full Text] [Related]
3. Advances in the targeted theragnostics of osteomyelitis caused by Staphylococcus aureus. Abdulrehman T; Qadri S; Haik Y; Sultan A; Skariah S; Kumar S; Mendoza Z; Yadav KK; Titus A; Khader S Arch Microbiol; 2024 Jun; 206(7):288. PubMed ID: 38834761 [TBL] [Abstract][Full Text] [Related]
4. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. Singh R; Ray P; Das A; Sharma M J Med Microbiol; 2009 Aug; 58(Pt 8):1067-1073. PubMed ID: 19528167 [TBL] [Abstract][Full Text] [Related]
5. Molecular reprogramming and phenotype switching in Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060 [No Abstract] [Full Text] [Related]
6. An in vitro biofilm model of Staphylococcus aureus infection of bone. Sweeney E; Lovering AM; Bowker KE; MacGowan AP; Nelson SM Lett Appl Microbiol; 2019 Apr; 68(4):294-302. PubMed ID: 30770577 [TBL] [Abstract][Full Text] [Related]
7. Bone grafts as vancomycin carriers in local therapy of resistant infections. Melicherčík P; Jahoda D; Nyč O; Klapková E; Barták V; Landor I; Pokorný D; Judl T; Sosna A Folia Microbiol (Praha); 2012 Sep; 57(5):459-62. PubMed ID: 22588620 [TBL] [Abstract][Full Text] [Related]
8. Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Hendrix AS; Spoonmore TJ; Wilde AD; Putnam NE; Hammer ND; Snyder DJ; Guelcher SA; Skaar EP; Cassat JE Antimicrob Agents Chemother; 2016 Sep; 60(9):5322-30. PubMed ID: 27324764 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic tolerance and the alternative lifestyles of Bui LM; Conlon BP; Kidd SP Essays Biochem; 2017 Feb; 61(1):71-79. PubMed ID: 28258231 [No Abstract] [Full Text] [Related]
11. Antibiotic delivery from bone-targeted mesoporous silica nanoparticles for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Aguilera-Correa JJ; Gisbert-Garzarán M; Mediero A; Fernández-Aceñero MJ; de-Pablo-Velasco D; Lozano D; Esteban J; Vallet-Regí M Acta Biomater; 2022 Dec; 154():608-625. PubMed ID: 36341887 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of the leading causative agents of osteomyelitis and their antibiotic resistance. Shipitsyna IV; Osipova EV; Astashova OA; Leonchuk DS Klin Lab Diagn; 2020 Sep; 65(9):562-566. PubMed ID: 33245642 [TBL] [Abstract][Full Text] [Related]
13. [Development of gentamicin-resistant Small Colony Variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence]. von Eiff C; Lindner N; Proctor RA; Winkelmann W; Peters G Z Orthop Ihre Grenzgeb; 1998; 136(3):268-71. PubMed ID: 9736990 [TBL] [Abstract][Full Text] [Related]
16. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. Ellington JK; Harris M; Hudson MC; Vishin S; Webb LX; Sherertz R J Orthop Res; 2006 Jan; 24(1):87-93. PubMed ID: 16419973 [TBL] [Abstract][Full Text] [Related]
17. When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus. Kuehl R; Morata L; Meylan S; Mensa J; Soriano A J Antimicrob Chemother; 2020 May; 75(5):1071-1086. PubMed ID: 32016348 [TBL] [Abstract][Full Text] [Related]
18. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Proctor RA; Kriegeskorte A; Kahl BC; Becker K; Löffler B; Peters G Front Cell Infect Microbiol; 2014; 4():99. PubMed ID: 25120957 [TBL] [Abstract][Full Text] [Related]
20. Daptomycin in bone and joint infections: a review of the literature. Rice DA; Mendez-Vigo L Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]